- |||||||||| RG7945 / Roche
Trial completion, Trial completion date, Trial primary completion date: A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - Mar 19, 2018
P1, N=52, Completed,
N=52 --> 27 Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Dec 2017 | Trial primary completion date: Sep 2018 --> Dec 2017
- |||||||||| RG7945 / Roche
Enrollment closed: A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - Feb 14, 2018
P1, N=52, Active, not recruiting,
Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Dec 2017 | Trial primary completion date: Sep 2018 --> Dec 2017 Recruiting --> Active, not recruiting
|
